Literature DB >> 9025012

Cognitive function in elderly non-insulin-dependent diabetic patients before and after inpatient treatment for metabolic control.

M Naor1, H J Steingrüber, K Westhoff, Y Schottenfeld-Naor, A F Gries.   

Abstract

Cognitive function was measured before and after inpatient treatment for metabolic control in 20 elderly patients with non-insulin-dependent diabetes mellitus (NIDDM). Another 20 patients still on the waiting list for this treatment, served as a control group. Glycosylated hemoglobin decreased in both groups. Psychomotor speed and concentration improved only after inpatient treatment (p < 0.01; p < 0.05, respectively). Improved performance was maintained and even enhanced 6 weeks after discharge from inpatient treatment. Performance in concentration tasks correlated with glycosylated hemoglobin (p < 0.05). It is concluded that cognitive deficits in elderly NIDDM patients can be reduced by inpatient treatment, although the benefit of glycemic control was not clearly demonstrated in this study.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9025012     DOI: 10.1016/1056-8727(95)00106-9

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  20 in total

Review 1.  Toward a model of memory enhancement in schizophrenia: glucose administration and hippocampal function.

Authors:  William S Stone; Larry J Seidman
Journal:  Schizophr Bull       Date:  2007-05-15       Impact factor: 9.306

Review 2.  Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia.

Authors:  Almudena Areosa Sastre; Robin Wm Vernooij; Magali González-Colaço Harmand; Gabriel Martínez
Journal:  Cochrane Database Syst Rev       Date:  2017-06-15

3.  Are neurocognitive speed and inconsistency similarly affected in type 2 diabetes?

Authors:  Bonnie P Whitehead; Roger A Dixon; David F Hultsch; Stuart W S MacDonald
Journal:  J Clin Exp Neuropsychol       Date:  2011-07       Impact factor: 2.475

4.  Decreased response inhibition in middle-aged male patients with type 2 diabetes.

Authors:  Kaya T Ishizawa; Hiroaki Kumano; Atsushi Sato; Hiroshi Sakura; Yasuhiko Iwamoto
Journal:  Biopsychosoc Med       Date:  2010-02-11

5.  Monounsaturated, trans, and saturated Fatty acids and cognitive decline in women.

Authors:  Asghar Z Naqvi; Brian Harty; Kenneth J Mukamal; Anne M Stoddard; Mara Vitolins; Julie E Dunn
Journal:  J Am Geriatr Soc       Date:  2011-05       Impact factor: 5.562

Review 6.  Type 2 diabetes and risk of cognitive impairment and dementia.

Authors:  Rachel A Whitmer
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

7.  Septal co-infusions of glucose with the benzodiazepine agonist chlordiazepoxide impair memory, but co-infusions of glucose with the opiate morphine do not.

Authors:  Desiree L Krebs-Kraft; Marise B Parent
Journal:  Physiol Behav       Date:  2009-12-22

8.  Hyperactivation of working memory-related brain circuits in newly diagnosed middle-aged type 2 diabetics.

Authors:  Xiao-Song He; Zhao-Xin Wang; You-Zhi Zhu; Nan Wang; Xiaoping Hu; Da-Ren Zhang; De-Fa Zhu; Jiang-Ning Zhou
Journal:  Acta Diabetol       Date:  2014-07-04       Impact factor: 4.280

Review 9.  Therapeutic Potential of Antidiabetic Medications in the Treatment of Cognitive Dysfunction and Dementia.

Authors:  Hiroyuki Umegaki
Journal:  Drugs Aging       Date:  2016-06       Impact factor: 3.923

Review 10.  Reassessment of Pioglitazone for Alzheimer's Disease.

Authors:  Ann M Saunders; Daniel K Burns; William Kirby Gottschalk
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.